FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4098211000001101: Daraprim 25mg tablets (GlaxoSmithKline) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17936901000001115 Daraprim 25mg tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58183501000001114 Daraprim 25mg tablets (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daraprim 25mg tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Is a Product containing precisely pyrimethamine 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Has excipient Lactose false Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Has active ingredient Pyrimethamine false Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Is a Daraprim true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Has specific active ingredient Pyrimethamine true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Daraprim 25mg tablets (GlaxoSmithKline) 30 tablet Is pack of False Daraprim 25mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Daraprim 25mg tablets (GlaxoSmithKline) 30 tablet Has AMP True Daraprim 25mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start